Bevacizumab/cetuximab/irinotecan
- 11 July 2020
- journal article
- case report
- Published by Springer Science and Business Media LLC in Reactions Weekly
- Vol. 1812 (1), 58
- https://doi.org/10.1007/s40278-020-80537-8
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case ReportCase Reports in Oncology, 2020